Treatment of Restless Legs Syndrome With the Hypocretin Antagonist Suvorexant
Condition:   Restless Legs Syndrome Interventions:   Drug: Suvorexant;   Drug: Placebo Sponsors:   Diego García-Borreguero, MD, PhD;   Sleep Research Institute (Paseo de la Habana 151, Madrid 28036, SPAIN) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2018 Category: Research Source Type: clinical trials

A Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome of Unknown Cause
Condition:   Restless Legs Syndrome Interventions:   Drug: Rotigotine 1 mg/24 h;   Drug: Rotigotine 2 mg/24 h;   Drug: Placebo Sponsor:   UCB Biopharma S.P.R.L. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2018 Category: Research Source Type: clinical trials